Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins

Dierks T, Schlotawa L, Frese M-A, Radhakrishnan K, von Figura K, Schmidt B (2009)
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH 1793(4): 710-725.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Abstract / Bemerkung
Multiple sulfatase deficiency (MSD), mucolipidosis (MIL) II/III and Niemann-Pick type C1 (NPC1) disease are rare but fatal lysosomal storage disorders caused by the genetic defect of non-lysosomal proteins. The NPC1 protein mainly localizes to late endosomes and is essential for cholesterol redistribution from endocytosed LDL to cellular membranes. NPC1 deficiency leads to lysosomal accumulation of a broad range of lipids. The precise functional mechanism of this membrane protein, however, remains puzzling. ML II, also termed I cell disease. and the less severe ML III result from deficiencies of the Golgi enzyme N-acetylglucosamine 1-phosphotransferase leading to a global defect of lysosome biogenesis. In patient cells, newly synthesized lysosomal proteins are not equipped with the critical lysosomal trafficking marker mannose 6-phosphate, thus escaping from lysosomal sorting at the trans Golgi network. MSD affects the entire sulfatase family, at least seven members of which are lysosomal enzymes that are specifically involved in the degradation of sulfated glycosaminoglycans, sulfolipids or other sulfated molecules. The combined deficiencies of all sulfatases result from a defective post-translational modification by the ER-localized formylglycine-generating enzyme (FGE), which oxidizes a specific cysteine residue to formylglycine, the catalytic residue enabling a unique mechanism of sulfate ester hydrolysis. This review gives an update on the molecular bases of these enigmatic diseases, which have been challenging researchers since many decades and so far led to a number of surprising findings that give deeper insight into both the cell biology and the pathobiochemistry underlying these complex disorders. In case of MSD, considerable progress has been made in recent years towards an understanding of disease-causing FGE mutations. First approaches to link molecular parameters with clinical manifestation have been described and even therapeutical options have been addressed. Further. the discovery of FGE as an essential sulfatase activating enzyme has considerable impact on enzyme replacement or gene therapy of lysosomal storage disorders caused by single sulfatase deficiencies. (C) 2008 Elsevier B.V. All rights reserved.
Erscheinungsjahr
Zeitschriftentitel
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Band
1793
Ausgabe
4
Seite(n)
710-725
ISSN
PUB-ID

Zitieren

Dierks T, Schlotawa L, Frese M-A, Radhakrishnan K, von Figura K, Schmidt B. Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2009;1793(4):710-725.
Dierks, T., Schlotawa, L., Frese, M. - A., Radhakrishnan, K., von Figura, K., & Schmidt, B. (2009). Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1793(4), 710-725. doi:10.1016/j.bbamcr.2008.11.015
Dierks, T., Schlotawa, L., Frese, M. - A., Radhakrishnan, K., von Figura, K., and Schmidt, B. (2009). Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH 1793, 710-725.
Dierks, T., et al., 2009. Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1793(4), p 710-725.
T. Dierks, et al., “Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins”, BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, vol. 1793, 2009, pp. 710-725.
Dierks, T., Schlotawa, L., Frese, M.-A., Radhakrishnan, K., von Figura, K., Schmidt, B.: Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 1793, 710-725 (2009).
Dierks, Thomas, Schlotawa, Lars, Frese, Marc-Andre, Radhakrishnan, Karthikeyan, von Figura, Kurt, and Schmidt, Bernhard. “Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins”. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH 1793.4 (2009): 710-725.

32 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The report of two cases with multiple sulfatase deficiency resulting from a rare similar gene mutation.
Ashrafzadeh F, Zabolinejad N, Ghayoor Karimiani E, Beiraghi Toosi M, Doniadideh N, Torabi S, Razmyar M, Sheikh Andalibi MS., Int J Dermatol 57(10), 2018
PMID: 29479672
GBA-Associated Parkinson's Disease and Other Synucleinopathies.
Gan-Or Z, Liong C, Alcalay RN., Curr Neurol Neurosci Rep 18(8), 2018
PMID: 29884970
Multiple Sulfatase Deficiency: A Case Series With a Novel Mutation.
Hijazi L, Kashgari A, Alfadhel M., J Child Neurol 33(13), 2018
PMID: 30124108
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities.
Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, Füllgrabe J, Jackson A, Jimenez Sanchez M, Karabiyik C, Licitra F, Lopez Ramirez A, Pavel M, Puri C, Renna M, Ricketts T, Schlotawa L, Vicinanza M, Won H, Zhu Y, Skidmore J, Rubinsztein DC., Neuron 93(5), 2017
PMID: 28279350
Natural disease history and characterisation of SUMF1 molecular defects in ten unrelated patients with multiple sulfatase deficiency.
Sabourdy F, Mourey L, Le Trionnaire E, Bednarek N, Caillaud C, Chaix Y, Delrue MA, Dusser A, Froissart R, Garnotel R, Guffon N, Megarbane A, Ogier de Baulny H, Pédespan JM, Pichard S, Valayannopoulos V, Verloes A, Levade T., Orphanet J Rare Dis 10(), 2015
PMID: 25885655
Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J, Böckenhoff A, Ewald B, Ladewig J, Eckhardt M, Gieselmann V, Matzner U, Brüstle O, Koch P., Mol Ther 23(9), 2015
PMID: 26061647
Eukaryotic formylglycine-generating enzyme catalyses a monooxygenase type of reaction.
Peng J, Alam S, Radhakrishnan K, Mariappan M, Rudolph MG, May C, Dierks T, von Figura K, Schmidt B., FEBS J 282(17), 2015
PMID: 26077311
The Regulation of Steroid Action by Sulfation and Desulfation.
Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA., Endocr Rev 36(5), 2015
PMID: 26213785
Dealing with oxygen using bare hands.
Mattevi A., FEBS J 282(17), 2015
PMID: 26179614
The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.
Bodamer OA, Giugliani R, Wood T., Mol Genet Metab 113(1-2), 2014
PMID: 25127543
A non-conserved miRNA regulates lysosomal function and impacts on a human lysosomal storage disorder.
Frankel LB, Di Malta C, Wen J, Eskelinen EL, Ballabio A, Lund AH., Nat Commun 5(), 2014
PMID: 25524633
Proprotein convertases process and thereby inactivate formylglycine-generating enzyme.
Ennemann EC, Radhakrishnan K, Mariappan M, Wachs M, Pringle TH, Schmidt B, Dierks T., J Biol Chem 288(8), 2013
PMID: 23288839
Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency.
Schlotawa L, Radhakrishnan K, Baumgartner M, Schmid R, Schmidt B, Dierks T, Gärtner J., Eur J Hum Genet 21(9), 2013
PMID: 23321616
Mixed modeling of meta-analysis P-values (MixMAP) suggests multiple novel gene loci for low density lipoprotein cholesterol.
Foulkes AS, Matthews GJ, Das U, Ferguson JF, Lin R, Reilly MP., PLoS One 8(2), 2013
PMID: 23405096
Arylsulfatase K, a novel lysosomal sulfatase.
Wiegmann EM, Westendorf E, Kalus I, Pringle TH, Lübke T, Dierks T., J Biol Chem 288(42), 2013
PMID: 23986440
The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A.
Rivera-Colón Y, Schutsky EK, Kita AZ, Garman SC., J Mol Biol 423(5), 2012
PMID: 22940367
Treatment options for lysosomal storage disorders: developing insights.
van Gelder CM, Vollebregt AA, Plug I, van der Ploeg AT, Reuser AJ., Expert Opin Pharmacother 13(16), 2012
PMID: 23009070
SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.
Schlotawa L, Ennemann EC, Radhakrishnan K, Schmidt B, Chakrapani A, Christen HJ, Moser H, Steinmann B, Dierks T, Gärtner J., Eur J Hum Genet 19(3), 2011
PMID: 21224894
Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.
Zhang XS, Brondyk W, Lydon JT, Thurberg BL, Piepenhagen PA., J Inherit Metab Dis 34(3), 2011
PMID: 21416197
Mucolipidosis type III α/β: the first characterization of this rare disease by autopsy.
Kerr DA, Memoli VA, Cathey SS, Harris BT., Arch Pathol Lab Med 135(4), 2011
PMID: 21466370
Golgi and related vesicle proteomics: simplify to identify.
Gannon J, Bergeron JJ, Nilsson T., Cold Spring Harb Perspect Biol 3(12), 2011
PMID: 21813401
Lysosomal degradation of membrane lipids.
Kolter T, Sandhoff K., FEBS Lett 584(9), 2010
PMID: 19836391
Cofactor-independent oxidases and oxygenases.
Fetzner S, Steiner RA., Appl Microbiol Biotechnol 86(3), 2010
PMID: 20157809
Multi-system disorders of glycosphingolipid and ganglioside metabolism.
Xu YH, Barnes S, Sun Y, Grabowski GA., J Lipid Res 51(7), 2010
PMID: 20211931
Pathophysiology of neuropathic lysosomal storage disorders.
Bellettato CM, Scarpa M., J Inherit Metab Dis 33(4), 2010
PMID: 20429032
Difficult intubation management in a child with I-cell disease.
M Mahfouz AK, George G, Al-Bahlani SS, Al Nabhani MZ., Saudi J Anaesth 4(2), 2010
PMID: 20927271
Pathology and current treatment of neurodegenerative sphingolipidoses.
Eckhardt M., Neuromolecular Med 12(4), 2010
PMID: 20730629
Myelin lesions associated with lysosomal and peroxisomal disorders.
Faust PL, Kaye EM, Powers JM., Expert Rev Neurother 10(9), 2010
PMID: 20819015
Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain.
Frese MA, Milz F, Dick M, Lamanna WC, Dierks T., J Biol Chem 284(41), 2009
PMID: 19666466

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 19124046
PubMed | Europe PMC

Suchen in

Google Scholar